Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Reproductive Health topic
No spam. Unsubscribe anytime.
House passes Fertility Treatment and Contraceptive Protection Act after heated floor debate over embryos and emergency contraceptives
Summary
The Tennessee House passed the Fertility Treatment and Contraceptive Protection Act (Senate Bill 449, carried on the floor as HB533), which codifies rights to fertility care and contraceptives, after extended debate over IVF, the legal status of embryos and whether the law would limit future regulation.
Get email alerts on the Reproductive Health topic
No spam. Unsubscribe anytime.
After several hours of floor debate, the Tennessee House passed Senate Bill 449 (considered on the floor as House Bill 533/substitute) on third and final consideration, enacting the “Fertility Treatment and Contraceptive Protection Act,” which the sponsor described as codifying the right of individuals to engage in fertility treatments and to access contraceptives and the right of health-care providers to provide those services. The bill’s sponsor told members the measure “does not mandate coverage nor impact regulations.” The House recorded the final vote as 54 ayes, 30 nays and 7 present/not voting; the Speaker declared the bill passed.
On the floor, the sponsor said the law would protect access to in vitro fertilization (IVF) and contraceptives in Tennessee, and asked members to codify the access into state law. The bill generated sustained debate from members concerned it would make future regulation difficult, and from members who said it was necessary to protect families currently accessing fertility treatment. Several amendments were offered on the floor:
- An amendment offered by Representative Balsow (amendment 2) would have (according to the sponsor’s summary on the floor) reaffirmed the policy that an embryo is an unborn child/person, clarified that the bill does not prohibit fertility treatment, and added a definition change to the contraceptive term to exclude abortion‑inducing drugs. Representative Balsow argued the bill as written created a statutory right to “create and destroy human embryos” without limitation. Representative Garrett and others opposed that floor amendment, arguing it raised complicated policy questions that should be considered in committee. The House voted to table amendment 2 (motion to table prevailed). Representatives argued for committee vetting versus immediate floor action.
- House amendment 4, offered by Leader Lambeth, was adopted on the floor. That amendment freezes any federal definition referenced in the bill to the federal code as of 07/01/2025, preventing future federal regulatory changes from automatically changing the state definition without subsequent state action. The House voted 82 ayes to 16 nays to adopt amendment 4.
Floor exchanges clarified that “emergency contraceptives,” as used in the bill, include Plan B (the “morning‑after pill”); a sponsor response on the floor confirmed the bill would preserve access to such products. Opponents said codifying the right could create legal obstacles to later regulation and expressed concerns about genetic testing and the status of embryos. Supporters, including the sponsor, said the bill merely codified access that already exists and that it would protect Tennessee families’ access to fertility treatment and contraception.
Representative remarks were personal and pointed: Representative Garrett described his daughter’s birth by fertility assistance and argued for committee vetting; Representative Williams and other supporters said the bill would help regulate bad actors and enable licensure/standards for clinics; other members said that passage would align state law to protect access. The House rejected several procedural attempts to cut off debate (the “previous question” failed at one point) before ultimately proceeding to a vote on the bill as amended.
The bill’s floor record includes multiple clarifications from members and the sponsor: the bill does not itself compel insurers to cover IVF or contraception; it does not, on the floor, change existing licensure authority but supporters said it should allow future licensure and regulation of IVF clinics. The floor debate was lengthy and featured statements about personal experience, legal philosophy about personhood, and concerns about future litigation. After the final tally the Speaker declared the bill passed.

